共 50 条
- [42] OPSONIC SPECIFICITY OF HUMAN-ANTIBODY TO THE TYPE-III POLYSACCHARIDE OF GROUP-B STREPTOCOCCUS JOURNAL OF INFECTIOUS DISEASES, 1979, 140 (06): : 1004 - 1008
- [43] RIFAMPIN TREATMENT OF INFANT RATS NASALLY COLONIZED WITH TYPE-III GROUP-B STREPTOCOCCI (GBS) CLINICAL RESEARCH, 1983, 31 (04): : A788 - A788
- [44] SPECIFICITY AND PROTECTIVE ACTIVITY OF MURINE MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE CAPSULAR POLYSACCHARIDE OF TYPE-III GROUP-B STREPTOCOCCI HYBRIDOMA, 1992, 11 (01): : 13 - 22
- [46] RELATION BETWEEN MATERNAL AGE AND SERUM CONCENTRATION OF IGG ANTIBODY TO TYPE-III GROUP-B STREPTOCOCCI JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (03): : 717 - 720
- [48] PHAGOCYTOSIS OF TYPE-III GROUP-B STREPTOCOCCI BY NEONATAL MONOCYTES - ENHANCEMENT BY FIBRONECTIN AND GAMMA-GLOBULIN JOURNAL OF INFECTIOUS DISEASES, 1985, 152 (04): : 695 - 700
- [49] COMPLEMENT IS REQUIRED FOR OPSONIZATION AND PROTECTION AGAINST TYPE-III GROUP-B STREPTOCOCCI BY HYBRIDOMA IGM ANTIBODY CLINICAL RESEARCH, 1983, 31 (01): : A118 - A118